Literature DB >> 17617788

Effect of treatment of Strongyloides infection on HTLV-1 expression in a patient with adult T-cell leukemia.

Lee Ratner1, Christian Grant, Bevin Zimmerman, Joseph Fritz, Gary Weil, Alex Denes, Rama Suresh, Nancy Campbell, Steve Jacobson, Michael Lairmore.   

Abstract

Human T-cell leukemia virus type 1 (HTLV-1) is associated with adult T-cell leukemia-lymphoma (ATLL) in about 5% of infected individuals. Coinfection by Strongyloides stercoralis has been suggested to be a cofactor for development of ATLL. We describe a patient who presented with HTLV-1-associated chronic ATLL and Strongyloides infection. Studies of this patient's viral RNA levels demonstrated stimulation of HTLV-1 replication by Strongyloides, which resolved with anti-helminthic therapy. This case provides support for the hypothesis that Strongyloides is a cofactor for ATLL via T-cell stimulation.

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17617788      PMCID： PMC2652703          DOI： 10.1002/ajh.20929

Source DB:  PubMed          Journal:  Am J Hematol        ISSN： 0361-8609            Impact factor:   10.047


  23 in total

1.  Correlation of human T-cell lymphotropic virus type 1 (HTLV-1) mRNA with proviral DNA load, virus-specific CD8(+) T cells, and disease severity in HTLV-1-associated myelopathy (HAM/TSP).

Authors:  Yoshihisa Yamano; Masahiro Nagai; Meghan Brennan; Carlos A Mora; Samantha S Soldan; Utano Tomaru; Norihiro Takenouchi; Shuji Izumo; Mitsuhiro Osame; Steven Jacobson
Journal:  Blood       Date:  2002-01-01       Impact factor: 22.113

2.  Coinfection by Strongyloides stercoralis in blood donors infected with human T-cell leukemia/lymphoma virus type 1 in São Paulo City, Brazil.

Authors:  P P Chieffi; C S Chiattone; E N Feltrim; R C Alves; M A Paschoalotti
Journal:  Mem Inst Oswaldo Cruz       Date:  2000 Sep-Oct       Impact factor: 2.743

3.  Deoxycoformycin-containing combination chemotherapy for adult T-cell leukemia-lymphoma: Japan Clinical Oncology Group Study (JCOG9109).

Authors:  Kunihiro Tsukasaki; Kensei Tobinai; Masanori Shimoyama; Mitsuo Kozuru; Naokuni Uike; Yasuaki Yamada; Masao Tomonaga; Koichi Araki; Masaharu Kasai; Kiyoshi Takatsuki; Mitsutoshi Tara; Chikara Mikuni; Tomomitsu Hotta
Journal:  Int J Hematol       Date:  2003-02       Impact factor: 2.490

4.  High circulating proviral load with oligoclonal expansion of HTLV-1 bearing T cells in HTLV-1 carriers with strongyloidiasis.

Authors:  A S Gabet; F Mortreux; A Talarmin; Y Plumelle; I Leclercq; A Leroy; A Gessain; E Clity; M Joubert; E Wattel
Journal:  Oncogene       Date:  2000-10-12       Impact factor: 9.867

5.  Increased activated human T cell lymphotropic virus type I (HTLV-I) Tax11-19-specific memory and effector CD8+ cells in patients with HTLV-I-associated myelopathy/tropical spastic paraparesis: correlation with HTLV-I provirus load.

Authors:  M Nagai; R Kubota; T F Greten; J P Schneck; T P Leist; S Jacobson
Journal:  J Infect Dis       Date:  2000-12-15       Impact factor: 5.226

6.  Involvement of IL-2/IL-2R system activation by parasite antigen in polyclonal expansion of CD4(+)25(+) HTLV-1-infected T-cells in human carriers of both HTLV-1 and S. stercoralis.

Authors:  Masao Satoh; Hiromu Toma; Kazuyuki Sugahara; Ken-ichiro Etoh; Yoshiyuki Shiroma; Susumu Kiyuna; Masahiro Takara; Masao Matsuoka; Kazunari Yamaguchi; Kiyonobu Nakada; Koichiro Fujita; Somei Kojima; Eitaro Hori; Yuetsu Tanaka; Shimeru Kamihira; Yoshiya Sato; Toshiki Watanabe
Journal:  Oncogene       Date:  2002-04-11       Impact factor: 9.867

7.  Human T-cell leukemia virus type 1 Tax interacts with Chk1 and attenuates DNA-damage induced G2 arrest mediated by Chk1.

Authors:  Hyeon Ung Park; Jae-Hoon Jeong; Jay H Chung; John N Brady
Journal:  Oncogene       Date:  2004-06-24       Impact factor: 9.867

Review 8.  Strongyloides stercoralis in the Immunocompromised Population.

Authors:  Paul B Keiser; Thomas B Nutman
Journal:  Clin Microbiol Rev       Date:  2004-01       Impact factor: 26.132

9.  Impairment of host immune response against strongyloides stercoralis by human T cell lymphotropic virus type 1 infection.

Authors:  Tetsuo Hirata; Nobufumi Uchima; Kazuto Kishimoto; Osamu Zaha; Nagisa Kinjo; Akira Hokama; Hiroshi Sakugawa; Fukunori Kinjo; Jiro Fujita
Journal:  Am J Trop Med Hyg       Date:  2006-02       Impact factor: 2.345

Review 10.  Seizing of T cells by human T-cell leukemia/lymphoma virus type 1.

Authors:  Genoveffa Franchini; Christophe Nicot; Julie M Johnson
Journal:  Adv Cancer Res       Date:  2003       Impact factor: 6.242
View more
  7 in total

1.  Mouse models of human T lymphotropic virus type-1-associated adult T-cell leukemia/lymphoma.

Authors:  B Zimmerman; S Niewiesk; M D Lairmore
Journal:  Vet Pathol       Date:  2010-05-04       Impact factor: 2.221

2.  The association of HTLV-1 infection, persistent intestinal infection with Strongyloides stercoralis and gastrointestinal lymphoma.

Authors:  Mehul Choksi; A J Joseph; Ebby Simon; Apurva Shah; Jeyamani Ramachandran; Balakrishnan S Ramakrishna
Journal:  BMJ Case Rep       Date:  2009-04-23

3.  Update on strongyloidiasis in the immunocompromised host.

Authors:  Luis A Marcos; Angélica Terashima; Marco Canales; Eduardo Gotuzzo
Journal:  Curr Infect Dis Rep       Date:  2011-02       Impact factor: 3.725

4.  Disseminated Strongyloides stercoralis infection in HTLV-1-associated adult T-cell leukemia/lymphoma.

Authors:  Donn M Stewart; Roshan Ramanathan; Siddhartha Mahanty; Daniel P Fedorko; John E Janik; John C Morris
Journal:  Acta Haematol       Date:  2011-04-07       Impact factor: 2.195

5.  Strongyloides stercoralis infection in the immunocompromised host.

Authors:  Roshan Ramanathan; Thomas Nutman
Journal:  Curr Infect Dis Rep       Date:  2008-05       Impact factor: 3.725

Review 6.  Strongyloidiasis Current Status with Emphasis in Diagnosis and Drug Research.

Authors:  Tiago Mendes; Karen Minori; Marlene Ueta; Danilo Ciccone Miguel; Silmara Marques Allegretti
Journal:  J Parasitol Res       Date:  2017-01-22

7.  Strongyloidiasis and infective dermatitis alter human T lymphotropic virus-1 clonality in vivo.

Authors:  Nicolas A Gillet; Lucy Cook; Daniel J Laydon; Carol Hlela; Kristien Verdonck; Carolina Alvarez; Eduardo Gotuzzo; Daniel Clark; Lourdes Farré; Achiléa Bittencourt; Becca Asquith; Graham P Taylor; Charles R M Bangham
Journal:  PLoS Pathog       Date:  2013-04-04       Impact factor: 6.823
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.